Skip to content
Subscriber Only

Stryker President’s Criminal Charges Dropped by Prosecutors

A former president at Stryker Corp. won’t be prosecuted on charges of marketing an unapproved mixture of two products for strengthening human bone growth, U.S. lawyers told a judge.

The government will abandon its 2009 indictment of Mark Philip, who ran Stryker Biotech LLC, prosecutors said today in federal court in Boston. The move follows the government’s decision last month to drop charges during the trial of three former Stryker sales representatives. Stryker, charged with a felony, pleaded guilty to a misdemeanor and paid a $15 million fine in connection with the unapproved marketing of the drugs.